Medicrea’s patient-specific UNiD™ Rod technology has now been used in >1,000 procedures, with >110 orthopaedic and neurosurgeons using the rods in Europe and the U.S.
UNiD technology was cleared to market in the U.S. in 4Q14.
The company expects its next FDA 510(k) clearance in coming weeks, for an extension to its complex spine portfolio of top-loading, self-locking tulip screws.
Medicrea's patient-specific UNiD™ Rod technology has now been used in >1,000 procedures, with >110 orthopaedic and neurosurgeons using the rods in Europe and the U.S.
UNiD technology was cleared to market in the U.S. in 4Q14.
The company expects its next FDA 510(k) clearance in coming weeks,...
Medicrea’s patient-specific UNiD™ Rod technology has now been used in >1,000 procedures, with >110 orthopaedic and neurosurgeons using the rods in Europe and the U.S.
UNiD technology was cleared to market in the U.S. in 4Q14.
The company expects its next FDA 510(k) clearance in coming weeks, for an extension to its complex spine portfolio of top-loading, self-locking tulip screws.
Copy to clipboard 
